ESR1 and inflammatory breast carcinoma: Previous studies showed conflicting findings on the prognosis of lobular carcinoma patients compared to IBC-NST [23, 24], although prevalent data were obtained by analyzing ER-positive invasive lobular carcinoma and IBC-NST.